News Announcement

Kwality Pharmaceuticals: Board Meeting Outcome for Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2024

Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations) this is to inform your that Board of Directors in its meeting held today i.e. October 30 2024 have inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30 2024 along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.